Multi-modal deep learning based on multi-dimensional and multi-level temporal data can enhance the prognostic prediction for multi-drug resistant pulmonary tuberculosis patients.
Sci One Health
; 1: 100004, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-39076608
ABSTRACT
Despite the advent of new diagnostics, drugs and regimens, multi-drug resistant pulmonary tuberculosis (MDR-PTB) remains a global health threat. It has a long treatment cycle, low cure rate and heavy disease burden. Factors such as demographics, disease characteristics, lung imaging, biomarkers, therapeutic schedule and adherence to medications are associated with MDR-PTB prognosis. However, thus far, the majority of existing studies have focused on predicting treatment outcomes through static single-scale or low dimensional information. Hence, multi-modal deep learning based on dynamic data for multiple dimensions can provide a deeper understanding of personalized treatment plans to aid in the clinical management of patients.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Sci One Health
Año:
2022
Tipo del documento:
Article
País de afiliación:
China